Inactive Instrument

Generex Biotechnology Corporation Stock

Equities

GNBT

US3714853013

Biotechnology & Medical Research

Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 61 17-11-20
Director of Finance/CFO - 16-12-31
Chief Operating Officer 65 18-06-24
Members of the board TitleAgeSince
Director/Board Member 63 04-02-29
Corporate Officer/Principal 66 04-12-31
Director/Board Member 57 17-11-20
More insiders
Generex Biotechnology Corporation is a life science holding company. The Company is engaged in pharmaceutical and biotechnological research and development and other activities. It is focused on building an organizational platform for the financing, development, commercialization and distribution of promising devices, biologics, therapeutic and diagnostic products to improve human health. The Company's subsidiary includes NuGenerex family of companies: NuGenerex Immuno-Oncology, Inc., NuGenerex Diagnostics, NuGenerex Health, LLC, NuGenerex Regenerative Medicine (NRM), NuGenerex Diagnostics (NGD), and NuGenerex Therapeutics. NuGenerex Immuno-Oncology, Inc. is a platform biotechnology company focused on improving the innate immune system to treat and prevent cancer and infectious disease with a pipeline of immunotherapy indications based on its patented platform technology.
More about the company